Chronic diarrhea
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]
Synonyms and keywords: prolonged diarrhea; chronic diarrhea of unknown origin; chronic small bowel diarrhea; chronic large bowel diarrhea; protracted diarrhea.
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]
Overview
Chronic diarrhea is a common symptom of many conditions and has an estimated prevalence of 5%. Although chronic diarrhea has multiple definitions, a current working definition is the production of loose stools for longer than 4 weeks. Frequent defecation with normal consistency is termed psuedodiarrhea. There are 3 basic categories of chronic diarrhea: watery, fatty (malabsorption), and inflammatory (with blood and pus). The fundamental pathophysiology of all diarrhea is altered intestinal water and electrolyte transport caused by several factors majorly dependent on the socioeconomic status of the population. If left untreated, patients with chronic diarrhea may progress to develop symptoms of altered sensorium due to electrolyte imbalance, dehydration, and malnutrition. Common complications of chronic diarrhea include confusion, perforated bowels, sepsis, and death. Prognosis is generally good when the underlying cause is identified and treated early. The laboratory findings in chronic diarrhea include complete blood count to evaluate for anemia and abnormal white blood cell count, electrolytes, thyroid function tests, serology testing for celiac disease, and stool analysis for fecal leukocytes, fecal lactoferrin, and fecal occult blood. Treatment is targeted at treating the underlying cause of the diarrhea.
Historical Perspective
The word “diarrhea” was coined by Hippocrates. Diarrhea is derived from the Greek term “to flow through.” Diarrhea is a common manifestation of gastrointestinal disease.
Classification
Chronic diarrhea may be classified into 3 basic categories: watery, fatty (malabsorption), and inflammatory (with blood and pus). It is important to note that not all chronic diarrhea falls into one category alone. Classifying a patient’s chronic diarrhea into a subcategory helps to direct the diagnostic workup.
Pathophysiology
The fundamental pathophysiology of all diarrhea is incomplete absorption of water from the lumen because of either a reduced rate of net water absorption or osmotic retention of water intraluminally. The causes of chronic diarrhea include inflammatory, osmotic, secretory, iatrogenic, motility, and functional diseases. Osmotic chronic diarrhea involves an unabsorbed substance that draws water from the plasma into the intestinal lumen along osmotic gradients. If excessive amounts of unabsorbed substance are retained in the intestinal lumen, water will not be absorbed and diarrhea will result. Secretory chronic diarrhea on the other hand, results from disordered electrolyte transport and, despite the term, is more commonly caused by decreased absorption rather than net secretion. A disruption of the normal colonic epithelial barrier by microorganisms is mainly responsible for inflammatory chronic diarrhea. This disruption can lead to exudative, secretory, or malabsorptive components of inflammatory chronic diarrhea. Both rapid transit time and slow transit time are associated with motility disorders causing chronic diarrhea. Some iatrogenic causes of chronic diarrhea are seen after abdominal surgeries such as cholecystectomy, where about 5%–10% of patients develop chronic diarrhea. In general, the causes of chronic diarrhea are multifactorial.
Causes
Depending on the socioeconomic status of the population, chronic diarrhea can be caused by several factors. In a developing nation, the most likely causes of chronic diarrhea are mycobacterial and parasitic infections, while functional disorders such as malabsorption and inflammatory bowel diseases are less likely causes. In a developed nation, however, the most likely causes of diarrhea are irritable bowel syndrome (IBS), inflammatory bowel disease, malabsorption syndromes (such as lactose intolerance and celiac disease), and chronic infections (particularly in patients who are immunocompromised).
Differentiating Chronic Diarrhea from other Conditions
The differential diagnosis for chronic diarrhea is enormous, with a large number of diagnostic tests available that can be used to evaluate these patients. Classifying a patient’s chronic diarrhea into a subcategory such as watery, fatty, and inflammatory helps to direct the diagnostic workup. Some watery causes of chronic diarrhea which should be differentiated from one another include Crohn’s disease, hyperthyroidism, VIPoma, lactose intolerance, celiac disease, and irritable bowel syndrome (IBS). The causes of fatty diarrhea that should be differentiated from one another include celiac sprue, pancreatic insufficiency, bacterial overgrowth, and maldigestion problems which results from pancreatic exocrine insufficiencyy. Finally, the inflammatory causes of chronic diarrhea such as diverticulitis, ulcerative colitis, and entamoeba histolytica must also be differentiated.
Epidemiology and Demographics
In developed countries, the prevalence of chronic diarrhea is estimated to be about 300-500 per 100,000 persons. In any given year, about 3–5% of the population has diarrhea lasting more than 1 month.
Risk Factors
The risk factors of chronic diarrhea can be assessed based on epidemiological associations and the patient‘s characteristics. Some of these factors can be classified based on travel history, epidemics and outbreaks, patients with acquired immune deficiency syndrome, and whether the patients are institutionalized or hospitalized.
Natural History, Complications, and Prognosis
If left untreated, patients with chronic diarrhea may progress to develop symptoms of altered sensorium due to electrolyte imbalance, dehydration, and malnutrition. Common complications of chronic diarrhea include confusion, perforated bowels, sepsis, and death. Prognosis is generally good when the underlying cause is identified and treated early.
Diagnosis
There are no criteria for the diagnosis of chronic diarrhea. However, in order to make an accurate diagnosis, it is important to take a detailed history and a physical exam from an expert’s opinion and from experience in individual clinical centers. The use of these methods is subject to bias; however, a specific diagnosis can be achieved in more than 90% of patients.
History and Symptoms
Obtaining the history of a patient is the most important aspect of making a diagnosis of chronic diarrhea. Specific histories about the symptoms (duration, onset, progression), associated symptoms, and drug usage have to be obtained. The hallmark of chronic diarrhea is loose stools lasting for 4 weeks or more. A positive history of foul smelling stools that are difficult to flush, bloody loose bowel movements, and cramping abdominal pain are suggestive of chronic diarrhea. The most common symptoms of chronic diarrhea include cramping abdominal pain, elevation in body temperature, and increased frequency of bowel movements.
Physical Examination
Some of the physical findings of chronic diarrhea are orthostatic hypotension, dehydration, neuropathy, muscle wasting, edema, malnutrition, urticaria pigmentosa, dermatographism, pinch purpura, macroglossia, hyperpigmentation, Addison’s disease, and migratory necrotizing erythema.
Laboratory Findings
The laboratory findings in chronic diarrhea include complete blood count to evaluate for anemia and abnormal white blood cell count, electrolytes, thyroid function tests, serology testing for celiac disease, and stool analysis for fecal leukocytes, fecal lactoferrin, and fecal occult blood. Some other diagnostic studies that have been adopted in the diagnosis of chronic diarrhea include flexible sigmoidoscopy, colonoscopy, esophagogastroduodenoscopy, and capsule endoscopy.
Electrocardiogram
There are no electrocardiogram findings associated with chronic diarrhea.
Chest X-Ray
There are no chest x-ray findings associated with chronic diarrhea.
CT Scan
There are no CT findings associated with chronic diarrhea.
Other Imaging Findings
There are no additional imaging findings for chronic diarrhea.
Treatment
Medical Therapy
Medications are the mainstay of treatment; the treatment of chronic diarrhea is targeted at treating the underlying cause. Antidiarrheal drugs, which act by improving stool consistency, reducing stool frequency, or reducing stool weight, are mainly employed for symptomatic treatment.
Surgery
Surgery is not the first-line treatment option for patients with chronic diarrhea. Surgical intervention is usually reserved for patients who have failed all medical therapy and when malignancy is suspected on biopsy as the cause of the chronic diarrhea.
Prevention
The primary and secondary prevention methods of chronic diarrhea are the same.
References
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]
Overview
The word “diarrhea” was coined by Hippocrates. Diarrhea is derived from the Greek term “to flow through.” Diarrhea is a common manifestation of gastrointestinal disease.
Historical Perspective
The word “diarrhea” was coined by Hippocrates. Diarrhea is derived from the Greek term “to flow through.” Diarrhea is a common manifestation of gastrointestinal disease.[1]
References
- ↑ Fine KD, Schiller LR (1999). “AGA technical review on the evaluation and management of chronic diarrhea”. Gastroenterology. 116 (6): 1464–86. PMID 10348832.
Classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]
Overview
Chronic diarrhea may be classified into 3 basic categories: watery, fatty (malabsorption), and inflammatory (with blood and pus). It is important to note that not all chronic diarrhea falls into one category alone. Classifying a patient’s chronic diarrhea into a subcategory helps to direct the diagnostic workup.
Classification
Chronic diarrhea may be classified into:[1][2][3][4]
Inflammatory diarrhea
Diarrhea may be classified as inflammatory, when stool analysis tools, such as stool cultures and interventions, such as flexible sigmoidoscopy or colonoscopy with biopsies show evidence of the presence of fecal leukocytes. Causes of inflammatory diarrhea include:
- Idiopathic inflammatory bowel disease, such as Crohn’s disease or ulcerative colitis
- Infectious diseases such as:
- Ischemic colitis
- Radiation colitis
- Neoplasia
Watery diarrhea
Watery diarrhea can be classified as:
A normal gap is between 50 and 100 mosm/kg.[6]
Fatty diarrhea
Fatty diarrhea can be either due to malabsorption or maldigestion problems:
- The most common causes of malabsorption are:
- Maldigestion results from pancreatic exocrine insufficiency
References
- ↑ Fine, K; Schiller, L (1999). “AGA Technical Review on the Evaluation and Management of Chronic Diarrhea☆”. Gastroenterology. 116 (6): 1464–1486. doi:10.1016/S0016-5085(99)70513-5. ISSN 0016-5085.
- ↑ “American Gastroenterological Association medical position statement: Guidelines for the evaluation and management of chronic diarrhea☆, ☆☆”. Gastroenterology. 116 (6): 1461–1463. 1999. doi:10.1016/S0016-5085(99)70512-3. ISSN 0016-5085.
- ↑ Camilleri M (2004). “Chronic diarrhea: a review on pathophysiology and management for the clinical gastroenterologist”. Clin Gastroenterol Hepatol. 2 (3): 198–206. PMID 15017602.
- ↑ Fine KD, Seidel RH, Do K (2000). “The prevalence, anatomic distribution, and diagnosis of colonic causes of chronic diarrhea”. Gastrointest Endosc. 51 (3): 318–26. PMID 10699778.
- ↑ Oster JR, Materson BJ, Rogers AI (1980). “Laxative abuse syndrome”. Am J Gastroenterol. 74 (5): 451–8. PMID 7234824.
- ↑ Shiau, Yih-Fu (1985). “Stool Electrolyte and Osmolality Measurements in the Evaluation of Diarrheal Disorders”. Annals of Internal Medicine. 102 (6): 773. doi:10.7326/0003-4819-102-6-773. ISSN 0003-4819.
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]
Overview
The fundamental pathophysiology of all diarrhea is incomplete absorption of water from the lumen because of either a reduced rate of net water absorption or osmotic retention of water intraluminally. The causes of chronic diarrhea include inflammatory, osmotic, secretory, iatrogenic, motility, and functional diseases. Osmotic chronic diarrhea involves an unabsorbed substance that draws water from the plasma into the intestinal lumen along osmotic gradients. If excessive amounts of unabsorbed substance are retained in the intestinal lumen, water will not be absorbed and diarrhea will result. Secretory chronic diarrhea on the other hand, results from disordered electrolyte transport and, despite the term, is more commonly caused by decreased absorption rather than net secretion. A disruption of the normal colonic epithelial barrier by microorganisms is mainly responsible for inflammatory chronic diarrhea. This disruption can lead to exudative, secretory, or malabsorptive components of inflammatory chronic diarrhea. Both rapid transit time and slow transit time are associated with motility disorders causing chronic diarrhea. Some iatrogenic causes of chronic diarrhea are seen after abdominal surgeries such as cholecystectomy, where about 5%–10% of patients develop chronic diarrhea. In general, the causes of chronic diarrhea are multifactorial.
Pathogenesis
Diarrhea is a condition of altered intestinal water and electrolyte transport. The physiological mechanisms of diarrhea include osmotic, secretory, inflammatory, altered motility, and iatrogenic mechanisms.[1]
Osmotic chronic diarrhea
Osmotic chronic diarrhea involves an unabsorbed substance that draws water from the plasma into the intestinal lumen along osmotic gradients. If excessive amounts of unabsorbed substance are retained in the intestinal lumen, water will not be absorbed and diarrhea will result.
- Chronic diarrhea due to an osmotic cause includes osmotic laxatives such as lactose intolerance antacids, fructose, lactulose, laxatives magnesium, phosphate, and sorbitol.[2]
- Maldigestion syndromes such as disaccharidase deficiency and pancreatic exocrine insufficiency can also result in osmotic chronic diarrhea.
- Osmotic diarrheas might result in steatorrhea and azotorrhea (passage of fat and nitrogenous substances into the stool), but they typically do not cause any rectal bleeding.[3]
Secretory chronic diarrhea
Secretory chronic diarrhea results from disordered electrolyte transport and, despite the term, is more commonly caused by decreased absorption rather than net secretion.
- Secretory diarrheas include congenital abnormalities such as congenital chloridorrhea, in which an abnormality in the genetic control of chloride-bicarbonate exchange in the ileum results in the loss of chloride into the stool.
- Another example is the loss of α2-adrenergic function in enterocytes of patients with autonomic neuropathy caused by diabetes mellitus.
- The typical features of secretory diarrhea include the persistence of the diarrhea with fasting and the absence of steatorrhea, azotorrhea, or blood per rectum.
- Secretory diarrheas caused by neuroendocrine tumors have been identified by measurement of plasma levels of the hormone or its metabolite in the urine.
- Investigations include measurements of VIP, gastrin, or calcitonin in plasma or 24-hour collections of urine for 5-hydroxyindoleacetic acid.[4]
Inflammatory chronic diarrhea
Disruption of the normal colonic epithelial barrier by microorganisms is mainly responsible for inflammatory chronic diarrhea. This disruption can lead to exudative, secretory, or malabsorptive components of inflammatory chronic diarrhea.
- Inflammatory causes of chronic diarrhea might present with features that suggest malabsorption or rectal bleeding.
- The nature of the malabsorption depends on the regions affected (e.g., proximal vs. distal small bowel), and rectal bleeding is usually a manifestation of colonic or rectal ulcerations.
- Anti-inflammatory agents, including bismuth subsalicylate or other, more potent anti-inflammatory medications, appear to benefit patients with microscopic or collagenous colitis.[5]
Motility disorders causing chronic diarrhea
Both rapid transit time and slow transit time are associated with motility disorders causing chronic diarrhea.
- Rapid transit time delivers fluid secreted during digestion to the distal small bowel or colon. This prevents reabsorption of normally secreted fluid in the small bowel, overwhelming the re-absorptive capacity of the colon.
- Slow transit time results in bacterial overgrowth with bile acid deconjugation, poor micelle formation, and steatorrhea.
- The clinical manifestations of chronic diarrhea caused by motility disorders include steatorrhea, usually up to 14 g per day.
- Osmotic laxatives result in acceleration of transit through the bowel, which is associated with up to 14 g of fat in the stool.
- Presence of more than 14 g per day of fat in the stool suggests the presence of bacterial overgrowth or associated disease such as celiac disease.[6]
Iatrogenic causes of chronic diarrhea
After abdominal surgeries such as cholecystectomy, about 5%–10% of patients develop chronic diarrhea.
- Most of these cases resolve completely or significantly improve within a couple of months.
- Iatrogenic diarrhea is related to excessive bile acids being delivered into the intestine.[7][8]
- After a cholecystectomy, bile is delivered directly into the small bowel, overcoming the terminal ileum‘s ability to reabsorb adequately, leading to cholerheic diarrhea.
- Some other iatrogenic causes of chronic diarrhea might result from vagal injury and ileal resection.
Genetics, Associated Conditions, Gross Pathology, and Microscopic Pathology
For the details of the genetics, associated conditions, gross and microscopic pathology of the following causes of chronic diarrhea, click the links below.
- Ulcerative colitis
- Crohn’s disease
- Lactose intolerance
- Celiac disease
- Chronic pancreatitis
- Cholera
- Microsporidiosis
- Giardiasis
- Cryptosporidiosis
- Hyperthyroidism
References
- ↑ Sweetser S (2012). “Evaluating the patient with diarrhea: a case-based approach”. Mayo Clin Proc. 87 (6): 596–602. doi:10.1016/j.mayocp.2012.02.015. PMC 3538472. PMID 22677080.
- ↑ Suarez FL, Savaiano DA, Levitt MD (1995). “A comparison of symptoms after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance”. N Engl J Med. 333 (1): 1–4. doi:10.1056/NEJM199507063330101. PMID 7776987.
- ↑ Morris AI, Turnberg LA (1979). “Surreptitious laxative abuse”. Gastroenterology. 77 (4 Pt 1): 780–6. PMID 467934.
- ↑ von der Ohe MR, Camilleri M, Kvols LK, Thomforde GM (1993). “Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea”. N Engl J Med. 329 (15): 1073–8. doi:10.1056/NEJM199310073291503. PMID 8371728.
- ↑ Pardi DS, Smyrk TC, Tremaine WJ, Sandborn WJ (2002). “Microscopic colitis: a review”. Am J Gastroenterol. 97 (4): 794–802. doi:10.1111/j.1572-0241.2002.05595.x. PMID 12003412.
- ↑ Hammer HF, Santa Ana CA, Schiller LR, Fordtran JS (1989). “Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose”. J Clin Invest. 84 (4): 1056–62. doi:10.1172/JCI114267. PMC 329760. PMID 2794043.
- ↑ Breuer NF, Jaekel S, Dommes P, Goebell H (1986). “Fecal bile acid excretion pattern in cholecystectomized patients”. Dig Dis Sci. 31 (9): 953–60. PMID 3731987.
- ↑ Arlow FL, Dekovich AA, Priest RJ, Beher WT (1987). “Bile acid-mediated postcholecystectomy diarrhea”. Arch Intern Med. 147 (7): 1327–9. PMID 3606289.
Causes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2] Anum Ijaz M.B.B.S., M.D.[3]
Overview
Depending on the socioeconomic status of the population, chronic diarrhea can be caused by several factors. In a developing nation, the most likely causes of chronic diarrhea are mycobacterial and parasitic infections, while functional disorders such as malabsorption and inflammatory bowel diseases are less likely causes. In a developed nation, however, the most likely causes of diarrhea are irritable bowel syndrome (IBS), inflammatory bowel disease, malabsorption syndromes (such as lactose intolerance and celiac disease), and chronic infections (particularly in patients who are immunocompromised).
Causes
Life threatening causes
There are no life-threatening causes of chronic diarrhea; however, complications resulting from untreated chronic diarrhea are common.
Common causes
In patients presenting with chronic diarrhea, the most frequent noninfectious causes include a mix of functional and organic disorders. Together, Functional diarrhea and Irritable Bowel Syndrome with Diarrhea (IBS-D) account for approximately 35% of cases.Other significant contributors include Lactase deficiency: 35% [1], Bile acid diarrhea: 25%–33%,[2], Celiac disease: 12% [3].
There following are some of the common causes of chronic diarrhea:[4][5][6][7][8]
| Etiology | Conditions |
| Malabsorption / Maldigestion | Celiac disease, Cystic fibrosis, Disaccharidase deficiency, Short gut syndrome, Intestinal lymphangiectasis. |
| Functional & Inflammatory | Irritable bowel syndrome (IBS), Inflammatory bowel disease (Crohn disease, Ulcerative colitis), Microscopic colitis. |
| Anatomic & Structural | Intussusception, Hirschsprung’s disease (with/without toxic megacolon), Partial bowel obstruction, Blind loop syndrome (associated with dysmotility) |
| Immunodeficiency | HIV, Severe combined immunodeficiency disorder (SCID), and other genetic disorders |
| Endocrine & Neoplastic | Hyperthyroidism, Addison’s disease, Carcinoid tumors, Vipoma, Gastrinoma (Zollinger-Ellison syndrome), Mastocytosis. |
| Infectious & Ischemic | Bacterial gastroenteritis, Viral gastroenteritis, Amebic dysentery, Infectious enteritis/colitis (non-C. diff), Ischemic colitis. |
| Miscellaneous Clinical | Antibiotic-associated diarrhea, Pseudomembranous colitis, Hemolytic uremic syndrome, Neonatal drug withdrawal |
| Drug Class | Common Agents |
| Gastrointestinal | Magnesium-containing antacids, Laxatives, Cisapride, Olsalazine |
| Cardiovascular | Digitalis, Quinidine, Procainamide, Hydralazine, Beta-blockers, ACE inhibitors, Diuretics. |
| Antimicrobials | Clindamycin, Ampicillin, Amoxycillin, Erythromycin, Cephalosporins. |
| Neuropsychiatric | Lithium, Fluoxetine, Alprazolam |
| Hypolipidemic | Clofibrate, Gemfibrozil, Lovastatin |
| Other Agents | Chemotherapeutic agents, NSAIDs, Thyroid hormones, Colchicine, Aminophylline, Salbutamol |
References
- ↑ Viswanathan L, Rao SS, Kennedy K, Sharma A, Yan Y, Jimenez E (July 2020). “Prevalence of Disaccharidase Deficiency in Adults With Unexplained Gastrointestinal Symptoms”. J Neurogastroenterol Motil. 26 (3): 384–390. doi:10.5056/jnm19167. PMID 32380581 Check
|pmid=value (help). - ↑ Sadowski DC, Camilleri M, Chey WD, Leontiadis GI, Marshall JK, Shaffer EA, Tse F, Walters JR (January 2020). “Canadian Association of Gastroenterology Clinical Practice Guideline on the Management of Bile Acid Diarrhea”. Clin Gastroenterol Hepatol. 18 (1): 24–41.e1. doi:10.1016/j.cgh.2019.08.062. PMID 31526844.
- ↑ Panezai MS, Ullah A, Ballur K, Gilstrap L, Khan J, Tareen B, Kakar M, Khan J, Rasheed A, Waheed A, Ghleilib I, White J, Cason FD (December 2021). “Frequency of Celiac Disease in Patients With Chronic Diarrhea”. Cureus. 13 (12): e20495. doi:10.7759/cureus.20495. PMID 35047307 Check
|pmid=value (help). - ↑ Jamma S, Rubio-Tapia A, Kelly CP, Murray J, Najarian R, Sheth S; et al. (2010). “Celiac crisis is a rare but serious complication of celiac disease in adults”. Clin Gastroenterol Hepatol. 8 (7): 587–90. doi:10.1016/j.cgh.2010.04.009. PMC 2900539. PMID 20417725.
- ↑ Manning AP, Thompson WG, Heaton KW, Morris AF (1978). “Towards positive diagnosis of the irritable bowel”. Br Med J. 2 (6138): 653–4. PMC 1607467. PMID 698649.
- ↑ Mekhjian HS, Switz DM, Melnyk CS, Rankin GB, Brooks RK (1979). “Clinical features and natural history of Crohn’s disease”. Gastroenterology. 77 (4 Pt 2): 898–906. PMID 381094.
- ↑ Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR; et al. (2005). “Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology”. Can J Gastroenterol. 19 Suppl A: 5A–36A. PMID 16151544.
- ↑ Veress B, Löfberg R, Bergman L (1995). “Microscopic colitis syndrome”. Gut. 36 (6): 880–6. PMC 1382626. PMID 7615277.
- ↑ Branski D, Lerner A, Lebenthal E (April 1996). “Chronic diarrhea and malabsorption”. Pediatr Clin North Am. 43 (2): 307–31. doi:10.1016/s0031-3955(05)70408-9. PMID 8614603.
- ↑ Kroschinsky F, Stölzel F, von Bonin S, Beutel G, Kochanek M, Kiehl M, Schellongowski P (April 2017). “New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management”. Crit Care. 21 (1): 89. doi:10.1186/s13054-017-1678-1. PMID 28407743.
- ↑ Philip NA, Ahmed N, Pitchumoni CS (February 2017). “Spectrum of Drug-induced Chronic Diarrhea”. J Clin Gastroenterol. 51 (2): 111–117. doi:10.1097/MCG.0000000000000752. PMID 28027072.
Differentiating Chronic Diarrhea from other Diseases

To review the differential diagnosis of diarrhea, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2], Seyedmahdi Pahlavani, M.D. [3]
Overview
The differential diagnosis for chronic diarrhea is enormous, with a large number of diagnostic tests available that can be used to evaluate these patients. Classifying a patient’s chronic diarrhea into a subcategory such as watery, fatty and inflammatory helps to direct the diagnostic work-up. Some watery causes of chronic diarrhea which should be differentiated from one another include crohn’s disease, hyperthyroidism, VIPoma, lactose intolerance, celiac disease and irritable bowel syndrome (IBS). The causes of fatty diarrhea that should be differentiated from one another include celiac sprue, pancreatic insufficiency, bacterial overgrowth and maldigestion problems which results from pancreatic exocrine insufficiency. Finally, the inflammatory causes of chronic diarrhea such as ulcerative colitis and entamoeba histolytica must also be differentiated.
Differential Diagnosis of Chronic Diarrhea from other diseases
The following table outlines the major differential diagnoses of chronic diarrhea.[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30]
Abbreviations: GI: Gastrointestinal, CBC: Complete blood count, WBC: White blood cell, RBC: Red blood cell, Plt: Platelet, Hgb: Hemoglobin, ESR: Erythrocyte sedimentation rate, CRP: C–reactive protein, IgE: Immunoglobulin E, IgA: Immunoglobulin A, ETEC: Escherichia coli enteritis, EPEC: Enteropathogenic Escherichia coli, EIEC: Enteroinvasive Escherichia coli, EHEC: Enterohemorrhagic Escherichia coli, EAEC: Enteroaggregative Escherichia coli, Nl: Normal, ASCA: Anti saccharomyces cerevisiae antibodies, ANCA: Anti–neutrophil cytoplasmic antibody, DNA: Deoxyribonucleic acid, CFTR: Cystic fibrosis transmembrane conductance regulator, SLC10A2: Solute carrier family 10 member 2, SeHCAT: Selenium homocholic acid taurine or tauroselcholic acid, IEL: Intraepithelial lymphocytes, MRCP: Magnetic resonance cholangiopancreatography, ANA: Antinuclear antibodies, AMA: Anti-mitochondrial antibody, LDH: Lactate dehydrogenase, CPK: Creatine phosphokinase, PCR: Polymerase chain reaction, ELISA: Enzyme–linked immunosorbent assay, LT: Heat–labile enterotoxin, ST: Heat–stable enterotoxin, RT-PCR: Reverse–transcriptase polymerase chain reaction, CD4: Cluster of differentiation 4, HIV: Human immunodeficiency virus, RUQ: Right-upper quadrant, VIP: Vasoactive intestinal peptide, GI: Gastrointestinal, FAP: Familial adenomatous polyposis, HNPCC: Hereditary nonpolyposis colorectal cancer, MTP: Microsomal triglyceride transfer protein, Scl‑70: Anti–topoisomerase I, TSH: Thyroid-stimulating hormone, T4: Thyroxine, T3: Triiodothyronine, DTR: Deep tendon reflex, RNA: Ribonucleic acid
| Cause | Clinical manifestation | Lab findings | Extra intestinal findings | Cause/Pathogenesis | Gold standard diagnosis | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Symptoms | GI signs | |||||||||||||||||||||
| Duration | Diarrhea | Fever | Abdominal pain | Weight loss | ||||||||||||||||||
| Stool exam | CBC | Other lab findings | ||||||||||||||||||||
| Acute | Chronic | Watery | Bloody | Fatty | WBC | RBC | Ova/Parasite | Osmotic gap | Other | WBC | Hgb | Plt | ||||||||||
| Crohn’s disease | – | + | + | + | + | ± | + | + |
|
+ | + | – | Nl | – | ↑ | ↓ | ↑ |
|
|
|
| |
| Ulcerative colitis | – | + | + | + | + | ± | + | + | + | + | – | Nl | – | ↑ | ↓ | ↑ |
|
|
| |||
| Celiac disease | – | + | ± | – | ± | – | + | + |
|
– | – | – | Nl |
|
Nl | ↓ | Nl |
|
| |||
| Cause | Duration | Diarrhea | Fever | Abdominal pain | Weight loss | GI signs | Stool exam | CBC | Other lab findings | Extra intestinal findings | Cause/Pathogenesis | Gold standard diagnosis | ||||||||||
| Acute | Chronic | Watery | Bloody | Fatty | WBC | RBC | Ova/Parasite | Osmotic gap | Other | WBC | Hgb | Plt | ||||||||||
| Cystic fibrosis | – | + | – | – | + | ± | + | + | – | – | – | Nl |
|
Nl | ↓ | Nl |
|
|
| |||
| Chronic pancreatitis | – | + | + | – | + | – | + | + | – | – | – | Nl |
|
Nl | Nl | Nl |
|
|||||
| Bile acid malabsorption | – | + | + | – | + | – | – | + | – | – | – | Nl |
|
Nl | Nl | Nl |
|
|
| |||
| Microscopic colitis | – | + | + | – | – | – | + | + | – | – | – | Nl | – | Nl | ↓ | Nl |
|
|
| |||
| Cause | Duration | Diarrhea | Fever | Abdominal pain | Weight loss | GI signs | Stool exam | CBC | Other lab findings | Extra intestinal findings | Cause/Pathogenesis | Gold standard diagnosis | ||||||||||
| Acute | Chronic | Watery | Bloody | Fatty | WBC | RBC | Ova/Parasite | Osmotic gap | Other | WBC | Hgb | Plt | ||||||||||
| Infective colitis | – | + | + | + | – | + | + | + |
|
+ | + | + | Nl |
|
↑ | ↓ | ↑ | |||||
| Ischemic colitis | + | + | + | + | – | + | + | + |
|
+ | + | – | Nl | – | ↑ | ↓ | ↑ |
|
|
| ||
| Lactose intolerance | + | + | + | – | – | – | + | – | – | – | – | ↑ | – | Nl | Nl | Nl |
|
|
| |||
| Irritable bowel syndrome | – | + | ± | – | ± | – | ± | – | – | – | – | Nl | – | Nl | Nl | Nl | Nl |
|
| |||
| Cause | Duration | Diarrhea | Fever | Abdominal pain | Weight loss | GI signs | Stool exam | CBC | Other lab findings | Extra intestinal findings | Cause/Pathogenesis | Gold standard diagnosis | ||||||||||
| Acute | Chronic | Watery | Bloody | Fatty | WBC | RBC | Ova/Parasite | Osmotic gap | Other | WBC | Hgb | Plt | ||||||||||
| Whipple’s disease | – | + | + | – | + | ± | + | + | – | – | – | Nl |
|
↓ | ↓ | ↓/↑ |
|
| ||||
| Tropical sprue | + | + | + | – | + | + | + | + |
|
+ | – | – | Nl |
|
Nl | ↓ | Nl |
| ||||
| Small bowel bacterial overgrowth | – | + | + | – | + | – | + | + | + | – | – | Nl |
|
Nl | ↓ | Nl |
|
| ||||
| Cause | Duration | Diarrhea | Fever | Abdominal pain | Weight loss | GI signs | Stool exam | CBC | Other lab findings | Extra intestinal findings | Cause/Pathogenesis | Gold standard diagnosis | ||||||||||
| Acute | Chronic | Watery | Bloody | Fatty | WBC | RBC | Ova/Parasite | Osmotic gap | Other | WBC | Hgb | Plt | ||||||||||
| Salmonellosis | + | + | + | + | – | + | + | – | + | + | – | Nl |
|
↑ | Nl | ↑ | ||||||
| Escherichia coli enteritis | EPEC | + | + | + | + | – | + | + | + |
|
+ | + | – | Nl |
|
↑ | Nl | Nl | – | – |
| |
| EAEC | + | + | + | + | – | – | + | – |
|
+ | + | – | Nl |
|
↑ | ↓ | ↓ | – |
|
|||
| Aeromonas | + | + | + | + | – | + | + | – |
|
+ | + | – | Nl |
|
↑ | Nl | Nl | – |
|
| ||
| Cause | Duration | Diarrhea | Fever | Abdominal pain | Weight loss | GI signs | Stool exam | CBC | Other lab findings | Extra intestinal findings | Cause/Pathogenesis | Gold standard diagnosis | ||||||||||
| Acute | Chronic | Watery | Bloody | Fatty | WBC | RBC | Ova/Parasite | Osmotic gap | Other | WBC | Hgb | Plt | ||||||||||
| Mycobacterium avium complex | + | + | + | + | – | + | + | – | + | + | – | Nl | – | ↓ | ↓ | Nl |
|
|||||
| CMV colitis | + | + | – | + | – | ± | + | – |
|
+ | + | – | Nl |
|
↓ | Nl | Nl |
|
| |||
| HIV | – | + | + | – | – | + | + | + | + | – | – | Nl | – | ↓ | ↓ | Nl |
|
|
| |||
| Cause | Duration | Diarrhea | Fever | Abdominal pain | Weight loss | GI signs | Stool exam | CBC | Other lab findings | Extra intestinal findings | Cause/Pathogenesis | Gold standard diagnosis | ||||||||||
| Acute | Chronic | Watery | Bloody | Fatty | WBC | RBC | Ova/Parasite | Osmotic gap | Other | WBC | Hgb | Plt | ||||||||||
| Entamoeba histolytica | + | + | + | + | – | + | + | – | + | + | + | Nl | – | ↑ | Nl | Nl | – |
|
| |||
| Giardia | – | + | + | – | + | – | + | + | – | – | + | Nl | – | Nl | Nl | Nl | – |
| ||||
| Cryptosporidium | – | + | + | – | – | – | + | + | – | – | + | Nl |
|
Nl | Nl | Nl |
|
|
| |||
| Microsporidia | + | + | + | – | – | + | + | – | – | – | + | Nl |
|
Nl | Nl | Nl |
|
| ||||
| Isospora | + | + | + | – | + | + | + | + | + | + | + | Nl |
|
↑ | Nl | Nl |
|
|
| |||
| Cause | Duration | Diarrhea | Fever | Abdominal pain | Weight loss | GI signs | Stool exam | CBC | Other lab findings | Extra intestinal findings | Cause/Pathogenesis | Gold standard diagnosis | ||||||||||
| Acute | Chronic | Watery | Bloody | Fatty | WBC | RBC | Ova/Parasite | Osmotic gap | Other | WBC | Hgb | Plt | ||||||||||
| Carcinoid tumor | – | + | + | + | – | – | + | + | – | + | – | ↓ | – | Nl | Nl | Nl |
|
|
| |||
| VIPoma | + | + | + | – | + | – | + | + |
|
– | – | – | ↓ | – | Nl | Nl | Nl |
|
|
| ||
| Zollinger–Ellison syndrome | – | + | + | + | + | – | + | + | – | – | – | ↓ | – | Nl | ↓ | Nl |
|
| ||||
| Somatostatinoma | – | + | + | – | – | – | + | + | – | – | – | ↓ | – | Nl | Nl | Nl |
|
|
| |||
| Cause | Duration | Diarrhea | Fever | Abdominal pain | Weight loss | GI signs | Stool exam | CBC | Other lab findings | Extra intestinal findings | Cause/Pathogenesis | Gold standard diagnosis | ||||||||||
| Acute | Chronic | Watery | Bloody | Fatty | WBC | RBC | Ova/Parasite | Osmotic gap | Other | WBC | Hgb | Plt | ||||||||||
| Lymphoma | – | + | + | + | – | + | + | + | – | + | – | Nl | – | Nl | ↓ | Nl |
|
| ||||
| Colorectal cancer | – | + | + | + | + | – | + | + |
|
– | + | – | Nl | – | Nl | ↓ | Nl |
|
| |||
| Medications | + | + | + | – | ± | ± | + | + | – | – | – | ↑/↓ | – | ↑ | Nl | Nl |
|
– |
| |||
| Factitious diarrhea | + | + | + | – | – | – | + | + | – | – | – | ↑/↓ | – | Nl | Nl | Nl |
| |||||
| Cause | Duration | Diarrhea | Fever | Abdominal pain | Weight loss | GI signs | Stool exam | CBC | Other lab findings | Extra intestinal findings | Cause/Pathogenesis | Gold standard diagnosis | ||||||||||
| Acute | Chronic | Watery | Bloody | Fatty | WBC | RBC | Ova/Parasite | Osmotic gap | Other | WBC | Hgb | Plt | ||||||||||
| Heavy metal ingestion | – | + | + | – | – | – | + | + | – | – | – | Nl | – | Nl | Nl | Nl |
|
| ||||
| Organophosphate poisoning | + | + | + | – | – | – | + | – | – | – | – | Nl | – | Nl | Nl | Nl |
|
|
|
| ||
| Opium withdrawal | + | + | + | – | – | – | + | – |
|
– | – | – | Nl | – | Nl | Nl | Nl |
| ||||
| Cause | Duration | Diarrhea | Fever | Abdominal pain | Weight loss | GI signs | Stool exam | CBC | Other lab findings | Extra intestinal findings | Cause/Pathogenesis | Gold standard diagnosis | ||||||||||
| Acute | Chronic | Watery | Bloody | Fatty | WBC | RBC | Ova/Parasite | Osmotic gap | Other | WBC | Hgb | Plt | ||||||||||
| Short bowel syndrome | + | + | + | – | + | – | – | + | – | – | – | Nl |
|
Nl | ↓ | ↑ |
|
|
|
| ||
| Radiation enteritis | + | + | + | + | + | – | + | + | + | + | – | Nl |
|
Nl | ↓ | Nl |
|
|
| |||
| Dumping syndrome | – | + | + | – | + | – | – | + |
|
– | – | – | Nl | – | Nl | Nl | Nl |
|
| |||
| Cause | Duration | Diarrhea | Fever | Abdominal pain | Weight loss | GI signs | Stool exam | CBC | Other lab findings | Extra intestinal findings | Cause/Pathogenesis | Gold standard diagnosis | ||||||||||
| Acute | Chronic | Watery | Bloody | Fatty | WBC | RBC | Ova/Parasite | Osmotic gap | Other | WBC | Hgb | Plt | ||||||||||
| Abetalipoproteinemia | – | + | + | – | + | – | + | + | – | – | – | Nl | – | Nl | Nl | Nl |
|
|
| |||
| Hyperthyroidism | – | + | + | – | – | ± | + | + | – | – | – | – | Nl |
|
Nl | Nl | Nl |
|
|
|||
| Diabetic neuropathy | – | + | + | – | + | – | + | + | – | – | – | Nl |
|
Nl | ↓ | Nl |
|
| ||||
| Systemic sclerosis | – | + | + | ± | + | – | + | + | – | + | – | Nl |
|
Nl | ↓ | Nl |
|
| ||||
References
- ↑ Casburn-Jones, Anna C; Farthing, Michael Jg (2004). “Traveler’s diarrhea”. Journal of Gastroenterology and Hepatology. 19 (6): 610–618. doi:10.1111/j.1440-1746.2003.03287.x. ISSN 0815-9319.
- ↑ Kamat, Deepak; Mathur, Ambika (2006). “Prevention and Management of Travelers’ Diarrhea”. Disease-a-Month. 52 (7): 289–302. doi:10.1016/j.disamonth.2006.08.003. ISSN 0011-5029.
- ↑ Pfeiffer, Margaret L.; DuPont, Herbert L.; Ochoa, Theresa J. (2012). “The patient presenting with acute dysentery – A systematic review”. Journal of Infection. 64 (4): 374–386. doi:10.1016/j.jinf.2012.01.006. ISSN 0163-4453.
- ↑ Barr W, Smith A (2014). “Acute diarrhea”. Am Fam Physician. 89 (3): 180–9. PMID 24506120.
- ↑ Amil Dias J (2017). “Celiac Disease: What Do We Know in 2017?”. GE Port J Gastroenterol. 24 (6): 275–278. doi:10.1159/000479881. PMID 29255768.
- ↑ Kotloff KL, Riddle MS, Platts-Mills JA, Pavlinac P, Zaidi A (2017). “Shigellosis”. Lancet. doi:10.1016/S0140-6736(17)33296-8. PMID 29254859. Vancouver style error: initials (help)
- ↑ Yamamoto-Furusho, J.K.; Bosques-Padilla, F.; de-Paula, J.; Galiano, M.T.; Ibañez, P.; Juliao, F.; Kotze, P.G.; Rocha, J.L.; Steinwurz, F.; Veitia, G.; Zaltman, C. (2017). “Diagnóstico y tratamiento de la enfermedad inflamatoria intestinal: Primer Consenso Latinoamericano de la Pan American Crohn’s and Colitis Organisation”. Revista de Gastroenterología de México. 82 (1): 46–84. doi:10.1016/j.rgmx.2016.07.003. ISSN 0375-0906.
- ↑ Borbély, Yves M; Osterwalder, Alice; Kröll, Dino; Nett, Philipp C; Inglin, Roman A (2017). “Diarrhea after bariatric procedures: Diagnosis and therapy”. World Journal of Gastroenterology. 23 (26): 4689. doi:10.3748/wjg.v23.i26.4689. ISSN 1007-9327.
- ↑ Crawford, Sue E.; Ramani, Sasirekha; Tate, Jacqueline E.; Parashar, Umesh D.; Svensson, Lennart; Hagbom, Marie; Franco, Manuel A.; Greenberg, Harry B.; O’Ryan, Miguel; Kang, Gagandeep; Desselberger, Ulrich; Estes, Mary K. (2017). “Rotavirus infection”. Nature Reviews Disease Primers. 3: 17083. doi:10.1038/nrdp.2017.83. ISSN 2056-676X.
- ↑ Kist M (2000). “[Chronic diarrhea: value of microbiology in diagnosis]”. Praxis (Bern 1994) (in German). 89 (39): 1559–65. PMID 11068510.
- ↑ Guerrant RL, Shields DS, Thorson SM, Schorling JB, Gröschel DH (1985). “Evaluation and diagnosis of acute infectious diarrhea”. Am. J. Med. 78 (6B): 91–8. PMID 4014291.
- ↑ López-Vélez R, Turrientes MC, Garrón C, Montilla P, Navajas R, Fenoy S, del Aguila C (1999). “Microsporidiosis in travelers with diarrhea from the tropics”. J Travel Med. 6 (4): 223–7. PMID 10575169.
- ↑ Wahnschaffe, Ulrich; Ignatius, Ralf; Loddenkemper, Christoph; Liesenfeld, Oliver; Muehlen, Marion; Jelinek, Thomas; Burchard, Gerd Dieter; Weinke, Thomas; Harms, Gundel; Stein, Harald; Zeitz, Martin; Ullrich, Reiner; Schneider, Thomas (2009). “Diagnostic value of endoscopy for the diagnosis of giardiasis and other intestinal diseases in patients with persistent diarrhea from tropical or subtropical areas”. Scandinavian Journal of Gastroenterology. 42 (3): 391–396. doi:10.1080/00365520600881193. ISSN 0036-5521.
- ↑ Mena Bares LM, Carmona Asenjo E, García Sánchez MV, Moreno Ortega E, Maza Muret FR, Guiote Moreno MV, Santos Bueno AM, Iglesias Flores E, Benítez Cantero JM, Vallejo Casas JA (2017). “75SeHCAT scan in bile acid malabsorption in chronic diarrhoea”. Rev Esp Med Nucl Imagen Mol. 36 (1): 37–47. doi:10.1016/j.remn.2016.08.005. PMID 27765536.
- ↑ Gibson RJ, Stringer AM (2009). “Chemotherapy-induced diarrhoea”. Curr Opin Support Palliat Care. 3 (1): 31–5. doi:10.1097/SPC.0b013e32832531bb. PMID 19365159.
- ↑ Abraham BP, Sellin JH (2012). “Drug-induced, factitious, & idiopathic diarrhoea”. Best Pract Res Clin Gastroenterol. 26 (5): 633–48. doi:10.1016/j.bpg.2012.11.007. PMID 23384808.
- ↑ Reintam Blaser A, Deane AM, Fruhwald S (2015). “Diarrhoea in the critically ill”. Curr Opin Crit Care. 21 (2): 142–53. doi:10.1097/MCC.0000000000000188. PMID 25692805.
- ↑ McMahan ZH, DuPont HL (2007). “Review article: the history of acute infectious diarrhoea management–from poorly focused empiricism to fluid therapy and modern pharmacotherapy”. Aliment. Pharmacol. Ther. 25 (7): 759–69. doi:10.1111/j.1365-2036.2007.03261.x. PMID 17373914.
- ↑ Schiller LR (2012). “Definitions, pathophysiology, and evaluation of chronic diarrhoea”. Best Pract Res Clin Gastroenterol. 26 (5): 551–62. doi:10.1016/j.bpg.2012.11.011. PMID 23384801.
- ↑ Giannella RA (1986). “Chronic diarrhea in travelers: diagnostic and therapeutic considerations”. Rev. Infect. Dis. 8 Suppl 2: S223–6. PMID 3523719.
- ↑ Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR; et al. (2005). “Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology”. Can J Gastroenterol. 19 Suppl A: 5A–36A. PMID 16151544.
- ↑ Sauter GH, Moussavian AC, Meyer G, Steitz HO, Parhofer KG, Jüngst D (2002). “Bowel habits and bile acid malabsorption in the months after cholecystectomy”. Am J Gastroenterol. 97 (7): 1732–5. doi:10.1111/j.1572-0241.2002.05779.x. PMID 12135027.
- ↑ Maiuri L, Raia V, Potter J, Swallow D, Ho MW, Fiocca R; et al. (1991). “Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia”. Gastroenterology. 100 (2): 359–69. PMID 1702075.
- ↑ RUBIN CE, BRANDBORG LL, PHELPS PC, TAYLOR HC (1960). “Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue”. Gastroenterology. 38: 28–49. PMID 14439871.
- ↑ Konvolinka CW (1994). “Acute diverticulitis under age forty”. Am J Surg. 167 (6): 562–5. PMID 8209928.
- ↑ Satsangi J, Silverberg MS, Vermeire S, Colombel JF (2006). “The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications”. Gut. 55 (6): 749–53. doi:10.1136/gut.2005.082909. PMC 1856208. PMID 16698746.
- ↑ Haque R, Huston CD, Hughes M, Houpt E, Petri WA (2003). “Amebiasis”. N Engl J Med. 348 (16): 1565–73. doi:10.1056/NEJMra022710. PMID 12700377.
- ↑ Hertzler SR, Savaiano DA (1996). “Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance”. Am J Clin Nutr. 64 (2): 232–6. PMID 8694025.
- ↑ Briet F, Pochart P, Marteau P, Flourie B, Arrigoni E, Rambaud JC (1997). “Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect?”. Gut. 41 (5): 632–5. PMC 1891556. PMID 9414969.
- ↑ BLACK-SCHAFFER B (1949). “The tinctoral demonstration of a glycoprotein in Whipple’s disease”. Proc Soc Exp Biol Med. 72 (1): 225–7. PMID 15391722.
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]
Overview
The prevalence of chronic diarrhea is estimated to be about 300-500 per 100,000 persons. In any given year, about 3–5% of the population has diarrhea lasting more than 1 month.
Prevalence
In developed countries, the prevalence of chronic diarrhea is estimated to be about 300-500 per 100,000 persons.[1][2][3]
For details about prevalence, incidence, age, and sex distribution of some of the causes of chronic diarrhea, click the links below:
- Ulcerative colitis
- Crohn’s disease
- Lactose intolerance
- Endocrine disorders such as hyperthyroidism
- Neuroendocrine tumors such as VIPoma
- Celiac disease
- Irritable bowel syndrome
- Giardiasis
- Tropical sprue
- Diverticulitis
- Clostridium difficile infection
- Ulcerating viral infections such as cytomegalovirus infection
- Invasive bacterial infections such as tuberculosis
- Neoplasias such as colorectal carcinoma
References
- ↑ Talley NJ, O’Keefe EA, Zinsmeister AR, Melton LJ (1992). “Prevalence of gastrointestinal symptoms in the elderly: a population-based study”. Gastroenterology. 102 (3): 895–901. PMID 1537525.
- ↑ Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ (1991). “Epidemiology of colonic symptoms and the irritable bowel syndrome”. Gastroenterology. 101 (4): 927–34. PMID 1889716.
- ↑ Sandler RS, Stewart WF, Liberman JN, Ricci JA, Zorich NL (2000). “Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact”. Dig Dis Sci. 45 (6): 1166–71. PMID 10877233.
Risk Factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]
Overview
The risk factors of chronic diarrhea can be assessed based on the epidemiologic associations and the patient’s characteristics. Some of these factors can be classified based on travel history, epidemics and outbreaks, diabetic patients, patients with acquired immune deficiency syndrome and whether the patients are institutionalized or hospitalized.
Risk Factors
The risk factors for chronic diarrhea include[1]
- Travel[2]
- Bacterial infection (mostly acute)
- Protozoal infections (eg, amebiasis, giardiasis)
- Tropical sprue
- Genetics
- Mutations in certain genes are associated with chronic diarrhea in inflammatory bowel diseases.
- Epidemics and outbreaks
- Bacterial infection
- Epidemic idiopathic secretory diarrhea (eg, Brainerd diarrhea)
- Protozoal infection (eg, cryptosporidiosis)
- Viral infection (eg, rotavirus)
- Diabetic patients
- Altered motility (increased or decreased)
- Pancreatic exocrine insufficiency
- Small Intestinal Bowel Obstruction
- Drugs (especially acarbose, metformin)
- Patients with acquired immunodeficiency syndrome
- Institutionalized and hospitalized patients
- Clostridium difficile infection
- Fecal impaction with overflow diarrhea
- Ischemic colitis
- Parenteral nutrition
Summary of Common Causes of Chronic Diarrhea and the associated Risk Factors[3]
| Condition | Worldwide prevalence | Risk factors |
| Functional diarrhea | 4.7% [4] | NA |
| Irritable bowel syndrome (IBS-D) | 1.2% [5] | |
| Disaccharidase deficiency | Prevalence estimate [9],[10] for loss of lactase enzyme activity is 60% globally in the adult population | |
| Microscopic colitis | Approximately 197.9 to 246.2 per 100,000 persons.[11],[12] |
|
| Celiac disease | 1.4%[17] based on positive celiac serologies
0.7% with biopsy-proven celiac disease (N = 138,792; meta-analysis of 57 population-based studies worldwide) |
|
| Exocrine Pancreatic Insufficiency (EPI) | Unknown | |
| Small Intestinal Bacterial Overgrowth (SIBO) | Unknown |
|
| Bile acid Diarrhea (BAD) | Approximately 1% of the general population. |
|
References
- ↑ Schiller LR, Pardi DS, Spiller R, Semrad CE, Surawicz CM, Giannella RA; et al. (2014). “Gastro 2013 APDW/WCOG Shanghai working party report: chronic diarrhea: definition, classification, diagnosis”. J Gastroenterol Hepatol. 29 (1): 6–25. doi:10.1111/jgh.12392. PMID 24117999.
- ↑ Duplessis, Christopher A.; Gutierrez, Ramiro L.; Porter, Chad K. (2017). “Review: chronic and persistent diarrhea with a focus in the returning traveler”. Tropical Diseases, Travel Medicine and Vaccines. 3 (1). doi:10.1186/s40794-017-0052-2. ISSN 2055-0936.
- ↑ Singh P, Lee A, Sheth NM, Chey WD (March 2026). “Chronic, Noninfectious Diarrhea: A Review”. JAMA. doi:10.1001/jama.2026.0872. PMID 41770539 Check
|pmid=value (help). - ↑ Palsson OS, Whitehead W, Törnblom H, Sperber AD, Simren M (April 2020). “Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom”. Gastroenterology. 158 (5): 1262–1273.e3. doi:10.1053/j.gastro.2019.12.021. PMID 31917991.
- ↑ Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, Whitehead WE, Dumitrascu DL, Fang X, Fukudo S, Kellow J, Okeke E, Quigley EM, Schmulson M, Whorwell P, Archampong T, Adibi P, Andresen V, Benninga MA, Bonaz B, Bor S, Fernandez LB, Choi SC, Corazziari ES, Francisconi C, Hani A, Lazebnik L, Lee YY, Mulak A, Rahman MM, Santos J, Setshedi M, Syam AF, Vanner S, Wong RK, Lopez-Colombo A, Costa V, Dickman R, Kanazawa M, Keshteli AH, Khatun R, Maleki I, Poitras P, Pratap N, Stefanyuk O, Thomson S, Zeevenhooven J, Palsson OS (January 2021). “Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study”. Gastroenterology. 160 (1): 99–114.e3. doi:10.1053/j.gastro.2020.04.014. PMID 32294476 Check
|pmid=value (help). - ↑ Sperber AD, Dumitrascu D, Fukudo S, Gerson C, Ghoshal UC, Gwee KA, Hungin AP, Kang JY, Minhu C, Schmulson M, Bolotin A, Friger M, Freud T, Whitehead W (June 2017). “The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review”. Gut. 66 (6): 1075–1082. doi:10.1136/gutjnl-2015-311240. PMID 26818616.
- ↑ Wang W, Wang M, Peng H, Huang J, Wu T (January 2024). “Association of major depressive disorder and increased risk of irritable bowel syndrome: A population-based cohort study and a two-sample Mendelian randomization study in the UK biobank”. J Affect Disord. 345: 419–426. doi:10.1016/j.jad.2023.10.111.
- ↑ Rahman MM, Ghoshal UC, Sultana S, Kibria MG, Sultana N, Khan ZA, Ahmed F, Hasan M, Ahmed T, Sarker SA (September 2018). “Long-Term Gastrointestinal Consequences are Frequent Following Sporadic Acute Infectious Diarrhea in a Tropical Country: A Prospective Cohort Study”. Am J Gastroenterol. 113 (9): 1363–1375. doi:10.1038/s41395-018-0208-3. PMID 30171215.
- ↑ 9.0 9.1 Swallow DM (2003). “Genetics of lactase persistence and lactose intolerance”. Annu Rev Genet. 37: 197–219. doi:10.1146/annurev.genet.37.110801.143820. PMID 14616060.
- ↑ 10.0 10.1 Scrimshaw NS, Murray EB (October 1988). “The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance”. Am J Clin Nutr. 48 (4 Suppl): 1079–159. doi:10.1093/ajcn/48.4.1142. PMID 3140651.
- ↑ Tome J, Sehgal K, Kamboj AK, Harmsen WS, Kammer PP, Loftus EV, Tremaine WJ, Khanna S, Pardi DS (May 2022). “The Epidemiology of Microscopic Colitis in Olmsted County, Minnesota: Population-Based Study From 2011 to 2019”. Clin Gastroenterol Hepatol. 20 (5): 1085–1094. doi:10.1016/j.cgh.2021.06.027. PMC 8716639 Check
|pmc=value (help). PMID 34216819 Check|pmid=value (help). - ↑ Weimers P, Ankersen DV, Lophaven S, Bonderup OK, Münch A, Løkkegaard EC, Burisch J, Munkholm P (December 2020). “Incidence and Prevalence of Microscopic Colitis Between 2001 and 2016: A Danish Nationwide Cohort Study”. J Crohns Colitis. 14 (12): 1717–1723. doi:10.1093/ecco-jcc/jjaa108. PMID 32502240 Check
|pmid=value (help). - ↑ Pardi DS, Loftus EV, Smyrk TC, Kammer PP, Tremaine WJ, Schleck CD, Harmsen WS, Zinsmeister AR, Melton LJ, Sandborn WJ (April 2007). “The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota”. Gut. 56 (4): 504–8. doi:10.1136/gut.2006.105890. PMC 1856874. PMID 17135309.
- ↑ Williams JJ, Kaplan GG, Makhija S, Urbanski SJ, Dupre M, Panaccione R, Beck PL (January 2008). “Microscopic colitis-defining incidence rates and risk factors: a population-based study”. Clin Gastroenterol Hepatol. 6 (1): 35–40. doi:10.1016/j.cgh.2007.10.031. PMID 18166476.
- ↑ Bergman D, Khalili H, Lebwohl B, Roelstraete B, Green PH, Ludvigsson JF (March 2023). “Celiac disease and risk of microscopic colitis: A nationwide population-based matched cohort study”. United European Gastroenterol J. 11 (2): 189–201. doi:10.1002/ueg2.12374. PMC 10039793 Check
|pmc=value (help). PMID 36939488 Check|pmid=value (help). - ↑ 16.0 16.1 Sikkens EC, Cahen DL, de Wit J, Looman CW, van Eijck C, Bruno MJ (2014). “A prospective assessment of the natural course of the exocrine pancreatic function in patients with a pancreatic head tumor”. J Clin Gastroenterol. 48 (5): e43–6. doi:10.1097/MCG.0b013e31829f56e7. PMID 24717227.
- ↑ Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, Kelly CP, Ahuja V, Makharia GK (June 2018). “Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis”. Clin Gastroenterol Hepatol. 16 (6): 823–836.e2. doi:10.1016/j.cgh.2017.06.037. PMID 29551598.
- ↑ 18.0 18.1 Singh P, Arora S, Lal S, Strand TA, Makharia GK (November 2015). “Risk of Celiac Disease in the First- and Second-Degree Relatives of Patients With Celiac Disease: A Systematic Review and Meta-Analysis”. Am J Gastroenterol. 110 (11): 1539–48. doi:10.1038/ajg.2015.296. PMID 26416192.
- ↑ Roy A, Laszkowska M, Sundström J, Lebwohl B, Green PH, Kämpe O, Ludvigsson JF (July 2016). “Prevalence of Celiac Disease in Patients with Autoimmune Thyroid Disease: A Meta-Analysis”. Thyroid. 26 (7): 880–90. doi:10.1089/thy.2016.0108. PMID 27256300.
- ↑ Machicado JD, Chari ST, Timmons L, Tang G, Yadav D (January 2018). “A population-based evaluation of the natural history of chronic pancreatitis”. Pancreatology. 18 (1): 39–45. doi:10.1016/j.pan.2017.11.012. PMC 5794616. PMID 29221631.
- ↑ Haupt ME, Kwasny MJ, Schechter MS, McColley SA (May 2014). “Pancreatic enzyme replacement therapy dosing and nutritional outcomes in children with cystic fibrosis”. J Pediatr. 164 (5): 1110–1115.e1. doi:10.1016/j.jpeds.2014.01.022. PMID 24560182.
- ↑ Ford AC, Spiegel BM, Talley NJ, Moayyedi P (December 2009). “Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis”. Clin Gastroenterol Hepatol. 7 (12): 1279–86. doi:10.1016/j.cgh.2009.06.031. PMID 19602448.
- ↑ Nyhlin H, Merrick MV, Eastwood MA (January 1994). “Bile acid malabsorption in Crohn’s disease and indications for its assessment using SeHCAT”. Gut. 35 (1): 90–3. doi:10.1136/gut.35.1.90. PMC 1374639. PMID 8307458.
Screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]
Overview
According to the USPSTF, screening for chronic diarrhea is not recommended.
Screening
According to the USPSTF, screening for chronic diarrhea is not recommended.
References
Natural History, Complications and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]
Overview
If left untreated, patients with chronic diarrhea may progress to develop symptoms of altered consciousness due to electrolyte imbalance, dehydration, and malnutrition. Common complications of chronic diarrhea include confusion, perforated bowels, sepsis, and death. Prognosis is generally good when the underlying cause is identified and treated early.
Natural History
Without treatment, the patient will develop symptoms of dehydration, malnutrition, altered mental status, sepsis, and eventually coma or death.
Complications
Complications that can develop as a result of chronic diarrhea are:
Prognosis
The prognosis of chronic diarrhea is good especially when the underlying cause is identified early and treated. The presence of these features in a patient complaining of diarrhea for over 4 weeks may indicate poor prognosis:[1][2][3][4][5]
- Dietary causes of diarrhea
- Rectal bleeding
- Weight loss
- Age > 50 years
- Pain
- Associated psychological factors
- Somatization
References
- ↑ Halfdanarson TR, Litzow MR, Murray JA (2007). “Hematologic manifestations of celiac disease”. Blood. 109 (2): 412–21. doi:10.1182/blood-2006-07-031104. PMC 1785098. PMID 16973955.
- ↑ Olesen M, Eriksson S, Bohr J, Järnerot G, Tysk C (2004). “Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998”. Gut. 53 (3): 346–50. PMC 1773978. PMID 14960513.
- ↑ Tillisch K, Labus JS, Naliboff BD, Bolus R, Shetzline M, Mayer EA; et al. (2005). “Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome”. Am J Gastroenterol. 100 (4): 896–904. doi:10.1111/j.1572-0241.2005.41211.x. PMID 15784038.
- ↑ . doi:10.1016/j.cgh.2006.11.024 showArticle Info Check
|doi=value (help). Missing or empty|title=(help) - ↑ Hammer HF, Fine KD, Santa Ana CA, Porter JL, Schiller LR, Fordtran JS (1990). “Carbohydrate malabsorption. Its measurement and its contribution to diarrhea”. J Clin Invest. 86 (6): 1936–44. doi:10.1172/JCI114927. PMC 329829. PMID 2254453.
Diagnosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
